<SEC-DOCUMENT>0001104659-17-009260-index.html : 20170214 <SEC-HEADER>0001104659-17-009260.hdr.sgml : 20170214 <ACCEPTANCE-DATETIME>20170214160733 ACCESSION NUMBER: 0001104659-17-009260 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20170214 DATE AS OF CHANGE: 20170214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-214882 FILM NUMBER: 17608696 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>424B3 <SEQUENCE>1 <FILENAME>a16-22161_1424b3.htm <DESCRIPTION>424B3 <TEXT> Document 1 - file: a16-22161_1424b3.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>g221611bmi001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: g221611bmi001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>g221611bmi002.gif <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: g221611bmi002.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>g221611bwi001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: g221611bwi001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g221611bwi002.gif <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g221611bwi002.gif
</DOCUMENT> </SEC-DOCUMENT>